姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Guo,Guo-Hua | Chairman | 24.58% | |
Zhan,Han-Shan | Director | 0.00% | |
Hong,Rong-Li | Director | 0.00% | |
Lin,Li-Wei | Independent Director | 0.00% | |
Lin,Zhi-Cong | Independent Director | 0.00% | |
Huang,Jun-Nong | Independent Director | 0.39% | |
Lin,Neng-Hui | Independent Director | 0.00% |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Operating income | 80,137 | 249,033 | 181,443 |
Operating cost | 11,828 | 43,689 | 36,856 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 68,309 | 205,344 | 144,587 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 68,309 | 205,344 | 144,587 |
Operating expenses | 28,500 | 85,698 | 63,903 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | 39,809 | 119,646 | 80,684 |
Non-operating income and expenses | 1,625 | 5,082 | 9,816 |
Net profit (loss) before tax | 41,434 | 124,728 | 90,500 |
Income tax expense (benefits) | 4,900 | 22,665 | 18,100 |
Net profit (loss) of ongoing business for the current period | 36,534 | 102,063 | 72,400 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 36,534 | 102,063 | 72,400 |
Other comprehensive profit (loss), net | - | - | - |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 36,534 | 102,063 | 72,400 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 0 | 1 | 1 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Current asset | 501,980 | 450,915 | 352,170 |
Non-current asset | 506,543 | 508,259 | 530,925 |
Total asset | 1,008,523 | 959,174 | 883,095 |
Current liability | 137,808 | 124,771 | 118,566 |
Non-current liability | 647 | 869 | 1,294 |
Total liability | 138,455 | 125,640 | 119,860 |
share capital | 589,996 | 589,996 | 556,600 |
Equity - secruity token | - | - | - |
capital reserve | 134,235 | 134,235 | 134,235 |
retained earning | 145,837 | 109,303 | 72,400 |
Other equity | - | - | - |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 870,068 | 833,534 | 763,235 |
Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 14 | 14 | 13 |